Form EFFECT Astria Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001140361-26-002204 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MedHaul Earns Top Honor in WellWithAll's $1 Million Prize for AI-Powered Innovation Changing Daily Health for the People Care Reaches Last
- Videa and ClearDent Partner to Bring Embedded AI Imaging to Canadian Dental Practices
- Cox Automotive Brings Xtime Technology into Technical Schools to Help Build the Next Generation of Auto Technicians
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share